• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer.

Polo-like kinase 1 (Plk1) inhibition synergizes with taxanes in triple negative breast cancer. PLoS One. 2019; 14(11):e0224420.

View in: PubMed

subject areas
  • Animals
  • Antineoplastic Combined Chemotherapy Protocols
  • Benzimidazoles
  • Cell Cycle Proteins
  • Cell Line, Tumor
  • Drug Resistance, Neoplasm
  • Drug Synergism
  • Female
  • Humans
  • Mice
  • Piperazines
  • Protein Kinase Inhibitors
  • Proto-Oncogene Proteins
  • Pyrazoles
  • Quinazolines
  • Thiophenes
  • Triple Negative Breast Neoplasms
  • Tumor Burden
  • Xenograft Model Antitumor Assays

authors with profiles
  • Kent E. Armeson
  • Stephen P. Ethier
  • Christiana S. Kappler
  • Antonio Giordano
  • Yeonhee Park